M&A Activity
Organigram – Sanity Group Deal: What Changed and What it Means for Germany
This article was originally published in February 2026, and was most recently updated on September 22, 2026.
German Cannabis Market
10stories
20 Septlast updated
More in German Cannabis Market
- Industry Trends
Cannabis Europa London 2026: Key Insights, Day 2
Live Cannabis Europa 2026 London, UK From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes Arjan Roskam, Green House Genetics; Dave Auger, Big League Genetics; Adele Hollman, Sanity Group; moderated by Alex Fraser, Grow Group Telemedicine in Germany: Maturity, Regulation and What Comes Next Kristine Lütke, 365 Sherpas GmbH; Dirk Heitepriem, German Cannabis…
- Industry Trends
Organigram Acquires Sanity Group: When Big Tobacco Moves into Cannabis
By Dr Sebastian Marincolo, Director of Strategic Content & Editorial, Weed.de Canadian cannabis company Organigram Global has agreed to acquire Berlin’s Sanity Group for up to 227 million euros, financed in large part by a roughly 65 million Canadian dollar capital injection from its largest shareholder, British American Tobacco (BAT).
- Industry Trends
Bundesrat Backs Tighter Cannabis Prescribing Rules, Rejects Mail-Order Penalties
Germany’s Bundesrat voted on November 21 to support key restrictions on medical cannabis prescribing and distribution, while rejecting proposals to ban prescriptions being sent via mail, a mixed outcome that offers both relief and concern for an industry bracing for regulatory tightening.
- Retail & Brands
Are Rival’s Challenges to High Tide’s German Entry About Compliance Or Competition?
Last month, one of Canada’s largest cannabis retailers, High Tide, thrust its way into the booming German medical cannabis market by acquiring a majority stake in Remexian Pharma GmbH in a deal worth over €27m.
- Companies
Curaleaf Partners with Medical Cannabis Clinicians Society to Strengthen UK Prescriber Education
The UK’s medical cannabis industry is now the second largest in Europe, second only to Germany, thanks to consistent and sustained growth over the last seven years.
- Press releases
Releaf Prepares to Launch Its ‘Technology-Led’ Medical Cannabis Model Internationally
Releaf, a leading UK medical cannabis clinic, has announced the launch of a new global expansion strategy as it prepares to take its proven healthcare model to new international markets.
